Related references
Note: Only part of the references are listed.Short- and Long-Term Effects of Cannabis on Headache and Migraine
Carrie Cuttler et al.
JOURNAL OF PAIN (2020)
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
Jeffrey Y. Hergenrather et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2020)
Migraine Epidemiology, Burden, and Comorbidity
Rebecca C. Burch et al.
NEUROLOGIC CLINICS (2019)
Does Medical Cannabis Reduce Use of Prescription Opioids?
Dennis McCarty
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Anti-migraine effect of Delta(9)-tetrahydrocannabinol in the female rat
Ram Kandasamy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Effects of Legal Access to Cannabis on Scheduled II-V Drug Prescriptions
Sarah S. Stith et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
Ashley C. Bradford et al.
JAMA INTERNAL MEDICINE (2018)
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Paula Berman et al.
SCIENTIFIC REPORTS (2018)
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
Casper Emil Christensen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study
Simon Haroutounian et al.
CLINICAL JOURNAL OF PAIN (2016)
Associations Between Sleep Quality and Migraine Frequency A Cross-Sectional Case-Control Study
Yu-Kai Lin et al.
MEDICINE (2016)
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
Danielle N. Rhyne et al.
PHARMACOTHERAPY (2016)
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Michelle Sexton et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
Chris Cameron et al.
HEADACHE (2015)
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
Sheena Derry et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Cannabis - from cultivar to chemovar
A. Hazekamp et al.
DRUG TESTING AND ANALYSIS (2012)
Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post-Discharge Medications
Nancy E. Kelley et al.
HEADACHE (2012)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
Min Yang et al.
CEPHALALGIA (2011)
Effects of anandamide in migraine: data from an animal model
Rosaria Greco et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Triptan Therapy in Migraine
Elizabeth Loder
NEW ENGLAND JOURNAL OF MEDICINE (2010)
NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data
Arpad Pardutz et al.
PHARMACEUTICALS (2010)
Degradation of endocannabinoids in chronic migraine and medication overuse headache
L. M. Cupini et al.
NEUROBIOLOGY OF DISEASE (2008)
Endocannabinoids in chronic migraine: CSF findings suggest a system failure
Paola Sarchielli et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
MA ElSohly et al.
LIFE SCIENCES (2005)
Migraine frequency and intensity: Relationship with disability and psychological factors
JE Magnusson et al.
HEADACHE (2003)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Ergotamine in the acute treatment of migraine - A review and European consensus
P Tfelt-Hansen et al.
BRAIN (2000)